The Trial, the Tame Trial, Anat Forman, the Tintrom.

The study is done in 14 centres across the united states that have experience with aging, and some of them with mformin through other studies. And we will recruit three thousand people between the ages 65 and 80, or 79, i should say. In a double blind placibo control study, we would look at outcomes. The primary outcome, from the fda perspective, is time until any one of the diseases,. you know, cardio vasculor conser a cognitive decline and mortality. We're going to show you that we delay everything.

Transcript

Play full episode

Transcript

Episode notes

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app